Better Biotech Stock to Buy With $1,500 Right Now: Viking Therapeutics vs. Summit Therapeutics [Yahoo! Finance]
Viking Therapeutics, Inc. (VKTX)
Last viking therapeutics, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.vikingtherapeutics.com
Company Research
Source: Yahoo! Finance
Viking Therapeutics (NASDAQ: VKTX) and Summit Therapeutics (NASDAQ: SMMT) are both up-and-coming biotechs with no sales revenue, plenty of cash in the bank, big catalysts on the horizon, and pipeline strategies that could place them in major markets relatively soon. That makes them more appealing than most biotech companies out there. It also makes deciding which one is worth an investment of around $1,500 a bit complicated. Let's shed some light on this issue by analyzing both stocks and seeing which might go to higher heights over the long term. The case for Viking Viking is about to enter the home stretch in its bid to develop a therapy to treat obesity. Its lead candidate, VK2735, will soon enter its phase 3 clinical trials to test its injectable formulation, and it'll also soon start phase 2 trials for its oral formulation. All the data the company has published so far suggests that its candidate is fairly powerful, as well as fairly tolerable for patients. If either of
Show less
Read more
Impact Snapshot
Event Time:
VKTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VKTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VKTX alerts
High impacting Viking Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
VKTX
News
- Viking Therapeutics to Report Financial Results for Third Quarter 2024 on October 23, 2024PR Newswire
- Viking Therapeutics, Inc. (NASDAQ: VKTX) was upgraded by analysts at StockNews.com to a "sell" rating.MarketBeat
- Is It Worth Investing in Viking Therapeutics (VKTX) Based on Wall Street's Bullish Views? [Yahoo! Finance]Yahoo! Finance
- Adrenoleukodystrophy Drug Pipeline Research Report 2024: Therapeutic Assessment, Emerging Drugs, Pipeline Development Activities, Competitive Landscape [Yahoo! Finance]Yahoo! Finance
- Where Will Viking Therapeutics Be in 5 Years? [Yahoo! Finance]Yahoo! Finance
VKTX
Earnings
- 7/24/24 - Beat
VKTX
Sec Filings
- 9/20/24 - Form 4
- 9/20/24 - Form 4
- 9/20/24 - Form 144
- VKTX's page on the SEC website